0001127602-14-026782.txt : 20140829
0001127602-14-026782.hdr.sgml : 20140829
20140829110451
ACCESSION NUMBER: 0001127602-14-026782
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140827
FILED AS OF DATE: 20140829
DATE AS OF CHANGE: 20140829
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
BUSINESS PHONE: 2054444600
MAIL ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAAB THOMAS R II
CENTRAL INDEX KEY: 0001230708
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 141073900
MAIL ADDRESS:
STREET 1: C/O INSPIRE PHARMACEUTICALS, INC.
STREET 2: 4222 EMPEROR BLVD., SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2014-08-27
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001230708
STAAB THOMAS R II
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior Vice President and CFO
Common Stock
2014-08-27
4
M
0
10000
5.45
A
172942
D
Common Stock
2014-08-27
4
S
0
10000
13.58
D
162942
D
Emp. Stock Option (Right to Buy)
5.45
2014-08-27
4
M
0
10000
0
D
2014-05-26
2023-08-08
Common Stock
10000
7000
D
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $13.42 to $13.75. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ Alane P. Barnes, by power of attorney
2014-08-28